Product NDC: | 55494-100 |
Proprietary Name: | DICLEGIS |
Non Proprietary Name: | doxylamine succinate and pyridoxine hydrochloride |
Active Ingredient(s): | 10; 10 mg/1; mg/1 & nbsp; doxylamine succinate and pyridoxine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55494-100 |
Labeler Name: | Duchesnay USA, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021876 |
Marketing Category: | NDA |
Start Marketing Date: | 20130515 |
Package NDC: | 55494-100-10 |
Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-10) |
NDC Code | 55494-100-10 |
Proprietary Name | DICLEGIS |
Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-10) |
Product NDC | 55494-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | doxylamine succinate and pyridoxine hydrochloride |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130515 |
Marketing Category Name | NDA |
Labeler Name | Duchesnay USA, Inc. |
Substance Name | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE |
Strength Number | 10; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |